Clinical Trial Update: Neoadjuvant Chemotherapy for Resectable Cancer of the Pancreatic Head [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant chemotherapy trial for resectable cancer of the pancreatic head has completed. The update notes the trial status as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: University of Zurich | Conditions: Cancer of the Pancreatic Head | Phase 2 | Status: COMPLETED